The first transplantation of stem cells in patients with Parkinson’s disease is almost within reach, say investigators. However, it remains a challenge for researchers to control stem cells accurately in the lab in order to achieve successful and functional stem cell therapies for patients.
Experimental drug shows promise in treating Alzheimer’s disease
An experimental drug shows promise in treating Alzheimer’s disease by preventing inflammation and removing abnormal protein clumps in the brain that are associated with the disease, suggests a new study in mice.
Viewpoints: Evidence In Support Of Medicaid Expansion; Too Much Reporting On Quality?
A selection of opinions on health care from around the country.
Viewpoints: The Future For Health Exchanges; More On Mylan, EpiPen And Profiteering
A selection of opinions on health care from around the country.
Protein linked to high risk of Alzheimer’s can be removed from brain without hindering learning, memory
A protein linked to higher risk of Alzheimer’s can be removed from the brains of mice without hindering memory and learning, according to a study that addresses whether potential therapeutics targeting this protein would have detrimental side effects.
Combination of complementary medicine, standard care helps reduce pre-op anxiety
A combination of complementary medicine and standard care shows potential to reduce preoperative anxiety levels and improve the outcome of the operation, state authors of a new report.
Viewpoints: Health Costs At Home And Abroad; Candidates’ Health Policy Details; VA And Suicides
A selection of opinions on health care from around the country.
Shape-shifting protein behind Alzheimer’s disease
The protein behind Alzheimer’s disease shape-shifts, changing its internal structure in order to infiltrate brain cells and become toxic, new research indicates.
State Highlights: Ind., Ohio Confront Overdoses From ‘Amped-Up’ Heroin; In N.Y., Few Homeless Shelter Workers Can Administer Narcan
Outlets report on health news from Indiana, Ohio, New York, Kansas, Virginia, Florida, Missouri, Georgia, Texas, Massachusetts, California and Michigan.
CMS Identifies Hospitals Paid Nearly $1.5B In 2015 Medicare Billing Settlement
A year after paying nearly $1.5 billion to more than a third of U.S. hospitals to resolve longstanding Medicare billing disputes, the Obama administration has disclosed who got paid.
NewYork-Presbyterian Hospital, one of the nation’s largest academic medical centers, received nearly $16 million, more than any other hospital, according to data released by the Centers for Medicare & Medicaid Services.
The second largest amount went to North Shore University Hospital in Manhasset, N.Y., which received $14.5 million. CHI Memorial Hospital in Chattanooga, Tenn., ranked third – $10.9 million – but two other New York-area hospitals rounded out the top five. Long Island Jewish Medical Center received $10.8 million and NYU Langone Medical Center was paid $10.5 million, the CMS data show.
In total, 2,022 hospitals shared in the government payout, which settled 346,000 claims for reimbursement for treating Medicare patients admitted on or before Oct. 1, 2013. The largest payments resolved thousands of claims at once. Memorial Hospital’s settlement covered nearly 3,000 claims.
The settlements were a compromise to reduce a swollen backlog of disputes over what hospitals argued they were owed. At one time, pending cases under appeal stretched more than two years.
The resolutions followed the government’s offer in 2014 to pay the hospitals 68 percent of the value of inpatient claims that had been caught in Medicare’s hearings and appeals process, some for years.
The new CMS data show 35 hospitals received more than $5 million each, but most were paid far less. The median payment – meaning half the hospitals got more and half got less – was $307,642, according to a Kaiser Health News analysis. The data was released in response to a Freedom of Information Act request made last year by KHN.
Medicare pays private contractors known as recovery audit contractors, or RACs, to review hospital claims for improper payments. If hospitals disagree with RACs’ decisions, they can appeal. Most RAC reviews have focused on costly inpatient-status claims, questioning whether certain patients should have been admitted to hospitals. Many audits determine that short patient stays should have been billed at less-costly outpatient rates.
Last year’s settlement indicated that many hospitals preferred to settle quickly for a discounted amount rather than keep claims tied up in appeals for what could have been months or even years. Hospitals that declined to settle with Medicare still had the option to continue their appeal.
Hospitals and RACs have long battled over audits and appeals. RACs – which are paid a fee for every audit that recovers money for Medicare – argue they are protecting taxpayer dollars and ensuring that hospitals are paid for appropriate patient services. Hospitals criticize the RAC process as burdensome and liken contractors to bounty hunters focused on making money for themselves.
CMS has said 18 percent of appealed claims were overturned in favor of hospitals between Oct. 1, 2013 and Sept. 30, 2014, but the American Hospital Association reported in 2014 that self-reported data by its members showed hospitals had won 66 percent of appeals since 2010.
The $1.5 billion paid in last year’s settlements contrast with more than $9.6 billion collected by RACs from 2010 through September 2015. More than 90 percent of collections by RACs were from hospitals.
Sydney Lupkin contributed to this report.